This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sweet, R. A. Articles by DeKosky, S. T. Search for Related Content PubMed PubMed Citation Articles by Sweet, R. A. Articles by DeKosky, S. T. Social Bookmarking                   What's this?

Apolipoprotein E and Alpha-1-Antichymotrypsin Genotypes Do Not Predict Time to Psychosis in Alzheimer's Disease

Division of Geriatrics and Neuropsychiatry, Department of Psychiatry

M. Ilyas Kamboh, PhD

Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvama

Stephen R. Wisniewski, PhD

Department of Epidemiology

Oscar L. Lopez, MD

Department of Neurology School of Medicine

William E. Klunk, MD, PhD

Division of Geriatrics and Neuropsychiatry, Department of Psychiatry

Daniel I. Kaufer, MD

Department of Neurology School of Medicine

Steven T. DeKosky, MD

Division of Geriatrics and Neuropsychiatry, Department of Psychiatry, Department of Neurology School of Medicine

Psychotic symptoms occurring in Alzheimer's disease (AD + psychosis, AD + P) are a marker for a more rapidly deteriorating phenotype. We have developed a polygenic model of AD + P risk, conditioned on the presence of AD. Whether risk genes for AD itself contribute to AD + P risk is not established, although our model predicts they will not. The most important identified genetic determinant of sporadic, late-onset AD is the apolipoprotein E epsilon 4 allele (APOE4). The effect of APOE4 on AD phenotype is to reduce the age of onset of AD. Prior studies examining the association of APOE4 with AD + P have reported conflicting results. However, no prior studies have examined if APOE4 reduces time to onset of psychosis in AD. The objective of this study was to examine the effect of APOE4 and 1-antichymotrypsin/AA (ACT/AA) genotypes on time to psychosis onset in subjects with AD. A longitudinal study of psychosis incidence in 316 subjects with AD with no history of current or prior psychotic symptoms at entry was undertaken. APOE and ACT genotyping was conducted per established protocols. Data were analyzed by survival analysis and Cox proportional hazards models. There were no significant associations of APOE or ACT genotypes with time to psychosis onset and no significant interaction of these genotypes with time to psychosis onset. There remained no significant associations after covarying for age, age ofAD onset, degree of cognitive impairment, gender, race, and education. This is the first study to examine the genetic prediction of psychosis onset in AD. The findings support the hypothesis that these two genetic determinants of AD risk do not contribute to the risk of development of psychotic symptoms in AD. (J Geriatr Psychiatry Neurol 2002; 15:24-30).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. A. Ropacki and D. V. Jeste Epidemiology of and Risk Factors for Psychosis of Alzheimer's Disease: A Review of 55 Studies Published From 1990 to 2003 Am J Psychiatry, November 1, 2005; 162(11): 2022 - 2030. [Abstract] [Full Text] [PDF]

				D Craig, D J Hart, K McCool, S P McIlroy, and A P Passmore Apolipoprotein E e4 allele influences aggressive behaviour in Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1327 - 1330. [Abstract] [Full Text] [PDF]

				J. Mintzer and S. D. Targum Psychosis in Elderly Patients: Classification and Pharmacotherapy J Geriatr Psychiatry Neurol, December 1, 2003; 16(4): 199 - 206. [Abstract] [PDF]

				S. E. Cook, S. Miyahara, S.-A. Bacanu, G. Perez-Madrinan, O. L. Lopez, D. I. Kaufer, V. L. Nimgaonkar, S. R. Wisniewski, S. T. DeKosky, and R. A. Sweet Psychotic Symptoms in Alzheimer Disease: Evidence for Subtypes Am J Geriatr Psychiatry, August 1, 2003; 11(4): 406 - 413. [Abstract] [Full Text] [PDF]